Medicine - Liver Diseases

Medicine & Life Sciences

1. Acute Liver Failure 8%
2. Alcoholic Hepatitis 10%
3. Alcohols 8%
4. Allografts 11%
5. alpha-Fetoproteins 5%
6. Antiviral Agents 19%
7. Apoptosis 7%
8. Ascites 5%
9. Autoimmune Hepatitis 13%
10. Autophagy 5%
11. Biliary Liver Cirrhosis 15%
12. Biomarkers 12%
13. Biopsy 12%
14. Cell Line 5%
15. Chemical and Drug Induced Liver Injury 9%
16. Cholangiocarcinoma 7%
17. Chronic Disease 11%
18. Chronic Hepatitis B 12%
19. Chronic Hepatitis C 27%
20. Clinical Trials 7%
21. Coinfection 10%
22. Collagen 8%
23. Confidence Intervals 5%
24. Coronavirus 5%
25. Discoidin Domain Receptor 2 5%
26. Elasticity Imaging Techniques 5%
27. End Stage Liver Disease 7%
28. Epigenomics 5%
29. Extracellular Matrix 7%
30. Fatty Liver 18%
31. Fibrosis 69%
32. Gastroenterology 5%
33. Gene Expression 6%
34. Genes 12%
35. Genotype 14%
36. Graft Survival 5%
37. Hepacivirus 78%
38. Hepatic Stellate Cells 52%
39. Hepatitis 13%
40. Hepatitis B 14%
41. Hepatitis B virus 14%
42. Hepatitis C 46%
43. Hepatocellular Carcinoma 100%
44. Hepatocytes 14%
45. HIV 30%
46. HIV Infections 6%
47. Incidence 6%
48. Infections 9%
49. Inflammation 7%
50. Interferons 18%
51. Kruppel-Like Factor 6 8%
52. Liver 81%
53. Liver Cirrhosis 34%
54. Liver Diseases 38%
55. Liver Neoplasms 21%
56. Liver Transplantation 76%
57. Living Donors 7%
58. Messenger RNA 5%
59. Mortality 9%
60. Mutation 8%
61. Myofibroblasts 5%
62. Neoplasms 26%
63. Non-alcoholic Fatty Liver Disease 20%
64. peginterferon alfa-2a 8%
65. Pharmaceutical Preparations 7%
66. Placebos 9%
67. Population 6%
68. Portal Hypertension 11%
69. Proteins 7%
70. ramucirumab 7%
71. Recurrence 10%
72. Ribavirin 28%
73. RNA 9%
74. Safety 9%
75. Sclerosing Cholangitis 6%
76. Serum 7%
77. Sofosbuvir 11%
78. sofosbuvir drug combination ledipasvir 6%
79. Sorafenib 18%
80. Survival 16%
81. Sustained Virologic Response 11%
82. telaprevir 6%
83. Tenofovir 5%
84. Therapeutics 28%
85. Tissue Donors 10%
86. Transcriptional Activation 5%
87. Transcriptome 5%
88. Transforming Growth Factors 7%
89. Transplant Recipients 16%
90. Transplantation 12%
91. Transplants 15%
92. Virus Diseases 18%
93. Wounds and Injuries 16%